SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
Speciality Chemical Resources, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
847-487-204
(CUSIP Number)
Terence J. Conklin
Trust Investments, Inc.
52 Stiles Road
Salem, NH 03079-4804
603-898-2002
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
December 22, 1995
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box.
Check the following box if a fee is being paid with the statement XX . (A fee is
not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 5 pages
SCHEDULE 13D
CUSIP No. 847-487-204 Page 2 of 5 pages
1. NAME OF REPORTING PERSON
S.S. OR IRS IDENTIFICATION NO. OF ABOVE PERSON
Martin Trust
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)
(b)
3. SEC USE ONLY
4. SOURCE OF FUNDS*
PF
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) OR 2(e)
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF SHARES BENEFICIALLY OWNED
BY EACH REPORTING PERSON WITH
NUMBER OF 7. SOLE VOTING POWER
SHARES 232,953
BENEFICIALLY
OWNED BY
EACH 8. SHARES VOTING POWER
REPORTING -0-
PERSON
WITH
9. SOLE DISPOSITIVE POWER
232,953
10. SHARED DISPOSITIVE POWER
- 0 -
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
232,953
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.9%
14. TYPE OF REPORTING PERSON
IN
* SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 2 of 5 pages
SCHEDULE 13D
Speciality Chemical Resources, Inc.
Item 1. Security and Issuer.
This statement relates to the Common Stock, $0.10 par value per
share (the "Common Stock"), of Speciality Chemical Resources, Inc., a
Delaware corporation (the "Issuer"), which has its principal executive
offices at 9100 Valley View Road, Macedonia, Ohio 44056.
Item 2. Identity and Background.
(a) Martin Trust.
(b) c/o Trust Investments, Inc.
52 Stiles Road
Salem, NH 03079-4804
(c) Private Investor
(d) During the last five years, Martin Trust has not been
convicted in a criminal proceeding (excluding traffic
violations and similar misdemeanors).
(e) During the last five years, Martin Trust was not a party to a
civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was
or is subject to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities
subject to, Federal or State securities laws or finding any
violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration.
Martin Trust purchased the shares of the Issuer with his personal
funds. 122,920 of the shares were purchased on December 22, 1995 (settlement
date December 28, 1995) for an aggregate purchase price of $276,570. 110,033
of the shares were purchased more than 60 days prior to December 22, 1995 for
an aggregate purchase price of $550,165.
Item 4. Purpose of Transaction.
Martin Trust has acquired the shares of the Issuer for the purpose
of making an investment in the Issuer in the ordinary course of his trade or
business. The shares of Common Stock of the Issuer acquired by Martin Trust
are being held solely for the purposes of investment. Such shares may be
disposed of at any time or from time to time in whole or in part. In addition,
Martin Trust may in the future acquire additional shares of Common Stock of the
Issuer.
Martin Trust does not at this time have any plans or proposals
which relate to or would result in any of the matters described in paragraphs
(a) through (j) of Item 4.
Item 5. Interest in Securities of the Issuer.
The aggregate number of shares of the Common Stock of the Issuer
beneficially owned by Martin Trust is 232,953 which is 5.9% of the Common Stock
of the Issuer (based on the number of securities outstanding as contained in
the most recently available filing with the Commission by the Issuer).
Page 3 of 5 pages
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to the Securities of the Issuer.
There are no contracts, arrangements, understandings or
relationships (legal or otherwise) between Martin Trust and any other person
with respect to any securities of the Issuer.
Item 7. Material to be Filed as Exhibits.
None.
Page 4 of 5 pages
Signatures
After reasonable inquiry and to the best knowledge and belief of
the undersigned, the undersigned certifies that the information set forth in
this statement is true, complete and correct.
/S/ Martin Trust
Martin Trust
Dated: December 30, 1995
Page 5 of 5 pages
